Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hibiki Kudamatsu"'
Autor:
Hibiki Kudamatsu, Takehiro Kawashiri, Keisuke Mine, Kohei Mori, Mizuki Inoue, Haruna Ishida, Mayako Uchida, Takashi Tsuchiya, Daisuke Kobayashi, Takao Shimazoe
Publikováno v:
Journal of Pharmacological Sciences, Vol 152, Iss 3, Pp 163-166 (2023)
Cachexia is a common cancer complication and is associated with weight loss and anorexia. In this study, we investigated the ameliorating effects of cystine and theanine on cancer cachexia using a mouse model. In mice carrying the colon cancer cell l
Externí odkaz:
https://doaj.org/article/c114b7b9461c45a0af827233a3034cea
Autor:
Kohei Mori, Takehiro Kawashiri, Keisuke Mine, Mizuki Inoue, Hibiki Kudamatsu, Mayako Uchida, Nobuaki Egashira, Daisuke Kobayashi, Takao Shimazoe
Publikováno v:
Toxics, Vol 10, Iss 11, p 669 (2022)
The anticancer drug, paclitaxel, is widely used for ovarian, breast, non-small cell lung, and gastric cancers; however, it induces peripheral neuropathy as a side effect. There is insufficient evidence-based prophylaxis, and new prophylaxis and treat
Externí odkaz:
https://doaj.org/article/c8d771654e88460093a1ab1ff136b22d
Autor:
Keisuke Mine, Takehiro Kawashiri, Mizuki Inoue, Daisuke Kobayashi, Kohei Mori, Shiori Hiromoto, Hibiki Kudamatsu, Mayako Uchida, Nobuaki Egashira, Satoru Koyanagi, Shigehiro Ohdo, Takao Shimazoe
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 8859 (2022)
(1) Background: Oxaliplatin is used as first-line chemotherapy not only for colorectal cancer but also for gastric and pancreatic cancers. However, it induces peripheral neuropathy with high frequency as an adverse event, and there is no effective pr
Externí odkaz:
https://doaj.org/article/2ff48ffd92ef413cbc81043edf7ad836
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
Autor:
Takehiro Kawashiri, Mizuki Inoue, Kohei Mori, Daisuke Kobayashi, Keisuke Mine, Soichiro Ushio, Hibiki Kudamatsu, Mayako Uchida, Nobuaki Egashira, Takao Shimazoe
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 16, p 8733 (2021)
Paclitaxel is an essential drug in the chemotherapy of ovarian, non-small cell lung, breast, gastric, endometrial, and pancreatic cancers. However, it frequently causes peripheral neuropathy as a dose-limiting factor. Animal models of paclitaxel-indu
Externí odkaz:
https://doaj.org/article/ae7a64258bdb4d079be811a8dd0c3be0
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
Autor:
Daisuke Kobayashi, Kohei Mori, Mayako Uchida, Takehiro Kawashiri, Keisuke Mine, Nobuaki Egashira, Soichiro Ushio, Takao Shimazoe, Hibiki Kudamatsu, Mizuki Inoue
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 8733, p 8733 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 8733, p 8733 (2021)
Paclitaxel is an essential drug in the chemotherapy of ovarian, non-small cell lung, breast, gastric, endometrial, and pancreatic cancers. However, it frequently causes peripheral neuropathy as a dose-limiting factor. Animal models of paclitaxel-indu